September 28, 2015 by Mark Baumgartner and Chain Drug Review
Health Affairs, J. Samantha Dougherty, Laura Miller, Medicaid, medication nonadherence, National Association of Chain Drug Stores, Pharmaceutical Research and Manufacturers of America, prescription drug use, Steve Anderson
2015, Issue 09-28-2015, Issues, News
ARLINGTON, Va. — An examination of data on more than 1.5 million Medicaid enrollees found that when prescription drugs are taken appropriately as prescribed by a physician there is a reduction of other medical costs for certain Medicaid populations. The research, undertaken to examine the impact of changes in prescription drug use on medical costs,
August 10, 2015 by John Schultz and Chain Drug Review
Affordable Care Act, Andy Slavitt, Centers for Medicare & Medicaid Services, CMS, Health Affairs, health insurance coverage, Medicaid, Medicare, U.S. health care spending
2015, Issue 08-10-2015, Issues, Leading Headlines, News
WASHINGTON — Total U.S. health care spending growth is expected to average 5.8% in aggregate over the 2014-2024 period, according to a report published in Health Affairs and written by members of the Centers for Medicare & Medicaid Services’ Office of the Actuary. The authors note that this rate of growth is still substantially lower
August 10, 2015 by John Schultz and Chain Drug Review
Affordable Care Act, Centers for Medicare and Medicaid Services, Medicaid at 50, Medicaid, Medicaid enrollment, Medicare, NACDS, National Association of Chain Drug Stores
2015, Issue 08-10-2015, Issues, News
WASHINGTON — Medicare and Medicaid recently passed the half-century mark, and the National Association of Chain Drug Stores envisions an enhanced role for pharmacists in both programs, particularly Medicaid. Congress, too, is looking for opportunities to strengthen and sustain Medicaid. Last month the House Energy and Commerce subcommittee on health held a hearing titled “Medicaid
April 27, 2015 by Geoff Walden and Chain Drug Review
Department of Health and Human Services, generic drug price increases, Generic Pharmaceutical Association, HHS, Medicaid, Ralph Neas, Rep. Elijah Cummings, Sen. Bernie Sanders
2015, Issue 04-27-2015, Leading Headlines, News, Pharmacy, Retail News
WASHINGTON — The federal government is looking into the effect of generic drug price increases on Medicaid. The Office of the Inspector General of the Department of Health and Human Services (HHS) will compare generic price increases between 2005 and 2014 to the inflation rate. The probe comes in response to questions raised about generics
February 16, 2015 by Geoff Walden and Chain Drug Review
Affordable Care Act, David French, Fred Upton, health insurance, Medicaid, National Retail Federation, Orrin Hatch, President Obama, Richard Burr
Issue 02-16-2015, News, Pharmacy
WASHINGTON — Three Republican lawmakers have proposed an alternative to the Affordable Care Act that would stop the expansion of Medicaid and reduce subsidies for middle-income people to buy insurance. The plan would give states more power to list “essential health benefits” of insurance. Coverage for maternity care would no longer be mandated. The proposal was
February 2, 2015 by Geoff Walden and Chain Drug Review
administrator, Affordable Care Act, Andrew Slavitt, Centers for Medicare and Medicaid Services, CMS, Department of Health and Human Services, health insurance exchange, HealthCare.gov, Marilyn Tavenner, Medicaid, Medicare, Sylvia Burwell
2015, Issue 02-02-2015, News, Pharmacy
WASHINGTON — Marilyn Tavenner is resigning as administrator of the Centers for Medicare and Medicaid Services. She will step down at the end of this month, she told CMS staff members in an e-mail. Principal deputy administrator Andrew Slavitt, who joined the agency last year to help fix HealthCare.gov, will be the acting administrator. Department of
January 19, 2015 by John Schultz and Chain Drug Review
AbbVie, commercial drug list, CVS Health, Express Scripts, Gilead Sciences, Harvoni, hepatitis C drug market, hepatitis C drugs, hepatitis C treatments, Medicaid, Medicare Part D, Sovaldi, Viekira Pak
2015, Issue 01-19-2015, News, Pharmacy
WOONSOCKET, R.I. — CVS Health and Gilead Sciences have reached a deal to make Gilead’s hepatitis C drugs, Harvoni and Sovaldi, the exclusive option for patients on its commercial drug list, as well as for those it manages on health care exchanges, Medicare Part D and Medicaid. The move partly counteracts a recent decision by